He said that for the average employer that covers these products for weight loss, GLP-1s now equate to about 3% of their total healthcare costs
Most first-time patients start with semaglutide, the most established GLP-1 medication
This novel GLP-1 receptor agonist, beyond its roots as a diabetes drug, has shown significant efficacy in promoting weight loss and improving metabolic health in adults with obesity, excluding those with diabetes
If you experience unusual fatigue, muscle pain, or metabolic symptoms after starting either supplement or medication, notify your healthcare provider promptly
In preclinical data, the pair improves adipocyte NAD+ by inhibiting NNMT, resulting in better fat metabolism and reduced obesity.[8][3] For anti-aging, this translates to improved tissue resilience and reduced senescence